EW r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Edwards Lifesciences R&D Expenses — Trailing twelve months (TTM) (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2026	1,090,600,000
Mar 31, 2026	1,087,900,000
Dec 31, 2025	1,079,200,000
Sep 30, 2025	1,082,600,000
Jun 30, 2025	1,055,300,000
Mar 31, 2025	1,051,700,000
Dec 31, 2024	1,053,800,000
Sep 30, 2024	1,024,800,000
Jun 30, 2024	1,014,200,000
Mar 31, 2024	985,300,000
Dec 31, 2023	989,800,000
Sep 30, 2023	979,900,000
Jun 30, 2023	970,700,000
Mar 31, 2023	977,800,000
Dec 31, 2022	945,200,000
Sep 30, 2022	945,800,000
Jun 30, 2022	950,200,000
Mar 31, 2022	924,700,000
Dec 31, 2021	903,100,000
Sep 30, 2021	866,000,000
Jun 30, 2021	823,500,000
Mar 31, 2021	780,300,000
Dec 31, 2020	760,700,000
Sep 30, 2020	758,900,000
Jun 30, 2020	758,900,000
Mar 31, 2020	768,700,000
Dec 31, 2019	752,700,000
Sep 30, 2019	721,900,000
Jun 30, 2019	688,200,000
Mar 31, 2019	650,400,000
Dec 31, 2018	622,200,000
Sep 30, 2018	605,700,000
Jun 30, 2018	586,800,000
Mar 31, 2018	567,100,000
Dec 31, 2017	552,599,999
Sep 30, 2017	520,899,999
Jun 30, 2017	490,999,999
Mar 31, 2017	469,499,999
Dec 31, 2016	443,200,000
Sep 30, 2016	426,500,000
Jun 30, 2016	414,500,000
Mar 31, 2016	399,100,000
Dec 31, 2015	383,100,000
Sep 30, 2015	368,900,000
Jun 30, 2015	355,500,000
Mar 31, 2015	347,100,000
Dec 31, 2014	346,500,000
Sep 30, 2014	341,100,000
Jun 30, 2014	337,600,000
Mar 31, 2014	329,000,000
Dec 31, 2013	323,000,000
Sep 30, 2013	319,300,000
Jun 30, 2013	309,000,000
Mar 31, 2013	302,500,000
Dec 31, 2012	291,300,000
Sep 30, 2012	277,100,000
Jun 30, 2012	265,000,000
Mar 31, 2012	255,900,000
Dec 31, 2011	246,300,000
Sep 30, 2011	241,500,000
Jun 30, 2011	232,500,000
Mar 31, 2011	218,200,000
Dec 31, 2010	204,400,000
Sep 30, 2010	196,800,000
Jun 30, 2010	188,800,000
Mar 31, 2010	180,800,000
Dec 31, 2009	175,500,000
Sep 30, 2009	163,000,000
Jun 30, 2009	153,400,000
Mar 31, 2009	146,200,000
Dec 31, 2008	139,200,000
Sep 30, 2008	136,900,000
Jun 30, 2008	132,700,000
Mar 31, 2008	126,400,000
Dec 31, 2007	122,300,000
Sep 30, 2007	118,800,000
Jun 30, 2007	116,000,000
Mar 31, 2007	115,800,000
Dec 31, 2006	114,000,000
Sep 30, 2006	109,800,000
Jun 30, 2006	105,700,000
Mar 31, 2006	101,000,000
Dec 31, 2005	99,000,000
Sep 30, 2005	96,600,000
Jun 30, 2005	94,500,000
Mar 31, 2005	91,000,000
Dec 31, 2004	87,000,000
Sep 30, 2004	82,600,000
Jun 30, 2004	77,500,000
Mar 31, 2004	74,800,000
Dec 31, 2003	72,800,000
Sep 30, 2003	71,500,000
Jun 30, 2003	70,200,000
Mar 31, 2003	68,800,000
Dec 31, 2002	65,200,000
Sep 30, 2002	61,900,000
Jun 30, 2002	60,400,000
Mar 31, 2002	57,300,000
Dec 31, 2001	55,000,000
Sep 30, 2001	55,300,000